Revisions Called for Usage Precautions on 196 Pharmaceutical Items

Published: 2005-01-03 07:00:00

Updated: 2005-01-03 07:00:00

The Korea Food and Drug Administration (KFDA) announced on December 30th that it has released instructions on revising the drug usage precautions for 196 pharmaceutical products from 13 active ingredient categories, based on their extensive safety reviews and analyses.

The 13 active ingredient categories affected by the revision are gadopentetic acid meglumine / meglumine (inj), gefinitib (t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.